Key result
HIV is linked to ~5.5-fold higher odds of myocardial fibrosis by LGE compared to controls.
Why the study?
HIV infection elevates the odds of cardiovascular diseases including myocardial fibrosis, motivating a systematic evaluation of CMR markers—LGE, ECV, T1, and T2—in patients living with HIV compared to healthy controls.
Does HIV infection increase cardiac magnetic resonance imaging markers of myocardial fibrosis (LGE, ECV, T1, and T2) in patients living with HIV compared to healthy controls?
Meta-Analysis (n=2,191)
Does HIV infection increase cardiac magnetic resonance imaging markers of myocardial fibrosis (LGE, ECV, T1, and T2) in patients living with HIV compared to healthy controls?
Patients living with HIV exhibit significantly elevated cardiac MRI markers of myocardial fibrosis (LGE, ECV, and T1 values) compared to healthy controls, despite no significant differences in LVEF or pro-BNP.
Supports intensified cardiac monitoring in PLWH; extends meta-analytic evidence for HIV-related myocardial fibrosis via CMR.
HIV infection significantly elevated the odds of cardiovascular diseases, including myocardial fibrosis. We aimed to determine the difference of late gadolinium enhancement (LGE), extracellular volume (ECV), T1, and T2 using cardiac magnetic resonance imaging (CMR) in patients living with HIV (PLWH) and healthy controls. The databases Scopus, Web of Science, Embase, and PubMed were searched systematically using relevant keywords. STATA version 17 was used for meta-analysis using random effect and fixed effect models for heterogeneous and non-heterogeneous analyses. An overall number of 13 studies were included in the current analysis involving 1425 PLWH and 766 healthy controls. PLWH showed significantly higher LGE (OR: 5.47, 95% CI: 1.90-15.64, p<0.001) and ECV (mean difference: 1.46, 95% CI: 0.21-2.71, p=0.02) compared to controls. However, differences in Left Ventricular Ejection Fraction (LVEF) were not significant (mean difference: −1.41, 95% CI: −2.81- −0.01, p=0.05). There were no meaningful disparities in pro B-type natriuretic peptide (BNP) values (mean difference: 8.67, 95% CI: 0.04-17.29, p=0.05) or T2 values (mean difference: 0.91 ms, 95% CI: −1.04-2.86, p=0.36), but T1 values were significantly higher in PLWH (mean difference: 13.78 ms, 95% CI: 9.16-18.40, p<0.001). In meta regression, LGE was correlated with nadir CD4 (z=-3.41, p-value<0.001). In addition, ECV was correlated with white race (Z=-3.97, p-value<0.001), Hepatitis C (Z=-2.08, p-value=0.037), and smoking (Z=2.05, p-value=0.041). HIV is related to a significantly elevated rate of myocardial fibrosis, and factors such as lower nadir CD4, white race, hepatitis C, and smoking were correlated with hepatitis C.
No takes yet. Share an insight, caveat, or question.
Shoar et al. (2026) conducted a meta-analysis in Myocardial fibrosis in patients living with HIV (n=2,191). HIV infection vs. Healthy controls was evaluated on Late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (OR 5.47, 95% CI 1.90-15.64, p=<0.001). Patients living with HIV had significantly higher odds of myocardial fibrosis by LGE (OR 5.47, 95% CI 1.90-15.64, p<0.001) and higher ECV (MD 1.46, p=0.02) than healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: